Privacy Policy
Signals Blog

Contributors

Categories

Day 1 at #TMM2013: Hongkui Deng breaks down iPS cells

> Set in the beautiful mountain setting of Banff National Park, the first hours of the Till and McCulloch meeting have not disappointed. Our morning plenary began with an excellent historical perspective from Shin-Ichi Nishikawa on the origins of blood stem cells...

Cell Therapy Industry 2027: A Vernian Voyage

. The Cell Therapy Industry’s equivalent of ‘Wimbledon Fortnight,’ is upon us: ARM’s successfully delivered Meeting on the Mesa (La Jolla, CA) has served as a tantalizing hors d’oeuvre to IBC’s Cell Therapy Bioprocessing Conference (Bethesda, MD) and CCRM’s and...

Jacob Hanna on Radically Deterministic Reprogramming @TMM2013

Guest post by Paul Knoepfler, cross-posted on ipscell.com What is “radically deterministic” cellular reprogramming? Jacob Hanna’s lab recently published a very high profile Nature paper on nearly 100% efficient iPS cell formation based on targeting a...

Right Turn: Life on Mars isn’t really lazy

. If you’ve been paying attention, Right Turn has brought you a variety of educational, amusing and hopefully thought-provoking posts. We have featured a rapping professor, photography, an infographics contest, TED Talks and so much more. But we’ve never had a Bruno...

Regenerative Medicine Deal Review

. Welcome to the first Regenerative Medicine Deal Review, an overview of recent licensing, partnering, and financing activity all exclusively in the regenerative medicine and cell therapy industries. Like my first post ‘Update from the Clinic’, this piece is intended...

StemCellShorts #2 – What are embryonic stem cells?

“Stem cell research is going to impact on the lives of all Canadians as we move to an era of new stem cell-based treatments for degenerative diseases.  StemCellShorts helps to engage the public in understanding the science of stem cells and I have been delighted to be...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!